Injectable Treatments Articles & Analysis: Older
5 articles found
Trofinetide (DaybueTM), developed by Acadia, is a peptide drug approved by the FDA for the treatment of Rett syndrome on March 10, 2023, making it the first FDA-approved Rett syndrome drug in history. ...
Similarly, the Covid-19 pandemic has demonstrated the importance of having preventive treatments for respiratory viruses. Interferon-alfa has potent anti-viral effects that can not only help to treat viral infection but also prevent them. ...
One of the important ways we participate is by helping to ensure safe injectable treatments, including safe vaccines. The critical impact of our role has become clear with the huge increase in urgent requests we have received from manufacturers around the world as they work to meet the demand for Covid ...
Now, a more sophisticated version of the same treatment is being used to treat extreme cases of COVID-19. But how does this treatment work and is it effective? ...
However, our goal at DiscGenics is to provide a cell therapy option that eliminates the need for sufferers of chronic low back pain to turn to opioids in the first place. We are developing an injectable disc cell therapy (IDCT) that has the potential to disrupt the way chronic back pain is treated. IDCT is an allogeneic, non-surgical cell therapy, meaning it’s an ...